Troscriptions

Supplement

Pharmaceutical-grade buccal troches, developed by physicians that leverage novel ingredients such as methylene blue, cordycepin, and agarin to enhance cellular function, stress, sleep, and immune resilience.

Services
  • Troscriptions
Location Dover, DE
About

Troscriptions

Troscriptions is a physician-formulated health optimization company delivering pharmaceutical-grade formulations via buccal troches for rapid, reliable absorption and high patient adherence. Developed by practicing clinicians, our products support mitochondrial function, cognitive performance, stress resilience, sleep, and inflammatory balance—tools practitioners can use now while guiding long-term optimization. No fluff. No guesswork. Just precision formulations designed to help you move patients toward measurable, repeatable physiologic balance — one troche at a time.

What We Offer

Services

Physician-formulated buccal troches for energy, focus, sleep, stress, and immune system optimization using novel compounds like methylene blue, cordycepin, agarin, and more.

Unlock exclusive discounts and offers from Troscriptions and other trusted partners with an SSRP Pro Membership.
What People Say

Testimonials

“Troscriptions has been integral in helping my patients recover from a variety of conditions that have stolen their energy and cognitive capacity. I’m thrilled by how many patients successfully transition off various medications with their help.”

Dr. Stephanie Rimka, DC
Dr. Stephanie Rimka, DC Dr. Stephanie Rimka

“Troscriptions products have been game changing in my clinical practice. Having tried numerous products, Troscriptions is the only brand that consistently receives glowing feedback from patients and truly moves the needle on their health challenges, something in only a few days.”

Dr. Ashley Beckman
Dr. Ashley Beckman Dr. Ashley
Network with our partners

Upcoming Events

View Upcoming Events
EVENT
Peptide Therapy Certification 2026
September 11 - 12, 2026

Peptide Therapy Certification 2026

View Event Details
RESOURCES

Join us in breaking down the latest research live.

VIEW ALL
SSRP Institute Aug 27, 2026
Rasonque: An FDA-Approved Drug to Treat Pancreatic Cancer
BREAKING NEWS August 26, 2026 – The Food and Drug Administration on Wednesday approved daraxonrasib, sold as Rasonque, for adults with metastatic pancreatic adenocarcinoma, the most common form of pancreatic cancer and one long considered among the hardest to treat. The once-daily tablet, developed by Revolution Medicines, is the first targeted therapy approved for the […]
READ NEWS
PODCAST
Redox Revolution
Aug 25, 2026
Ep.74 – Girls and Sports Injuries: Is There An Epidemic We’re Not Paying Attention To?
Ep.74 – Girls and Sports Injuries: Is There An Epidemic We’re Not Paying Attention To?

In this episode of Redox Revolution, Dr. Seeds discusses the rising prevalence of sports-related injuries in young women and girls. Why this increase? What’s at stake?

Performance & Recovery · Women's Health
VIDEO
Cellular Medicine Mondays
Aug 24, 2026
Ep. 102 - Office Hours: PWC26 Virtual Summit Part 4
Preview Only
Office Hours PWC26 Virtual Summit Part 4 – Episode 102

Office Hours PWC26 Virtual Summit Part 4- Episode 102

  1. Compounded topical creams and GHK-Cu with microneedling (0:59)
  2. Detoxing before using copper (12:09)
  3. Patient onboarding process (12:54)
  4. Zinc and iron supplementation with GHK-Cu (23:41)
  5. Loss of taste after COVID (25:55)
  6. 3D CT scans for root canals (27:03)
  7. Oral bacteria swabs and GLP-1 effectiveness (28:00)
  8. Endocannabinoid system (29:07)
  9. GHK-Cu efficacy on wound beds (32:05)

Preview Only — Become a member for full access
SSRP Institute Aug 21, 2026
Alpha-Gal Syndrome: An Update on Incidence Rate by the CDC
HEADLINE SCIENCE JAMA recently published a report about the incidence rate of alpha-gal syndrome, which is a serious allergic reaction to a sugar molecule called alpha-gal, which is found in most mammals. It is typically transmitted through a bite from a Lone Star tick or other tick species that injects the molecule into the body, […]
READ NEWS
IntellxxDNA Aug 12, 2026
SSRP Institute Welcomes IntellxxDNA as New Trusted Partner
PARTNER ANNOUNCEMENT WILLOUGHBY, Ohio, [August 12, 2026] — The SSRP Institute welcomes IntellxxDNA to its Trusted Partner Network following a nomination and internal vetting process, aligning with SSRP’s mission to advance science-first, education-driven clinical collaboration. IntellxxDNA provides clinicians with a structured genomic decision support platform that translates complex genetic data into clinically actionable insights. Using […]
READ NEWS
ARTICLE
William Seeds, MD
Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
William Seeds, MD Aug 6, 2026
A Lipid at the Root of Mitochondrial Aging: Phosphatidylcholine, Methylation, and a Malleable Therapeutic Window
Mitochondrial dysfunction is one of the most firmly established hallmarks of aging, but the field has spent far more energy describing genetic causes of mitochondrial failure—mtDNA mutation, defective OXPHOS, impaired unfolded protein response—than the “natural” drivers that erode mitochondria during ordinary aging. As I discussed in my recent June Journal Club (as well as a […]
READ ARTICLE
SSRP Institute Jul 24, 2026
PCAC Meeting Vote Summary
BREAKING NEWS JULY 24, 2026 – The Pharmacy Compounding Advisory Committee (PCAC) has completed its July session, voting on several peptide bulk drug substances for potential inclusion on the FDA’s 503A Bulks List.Recommended FOR inclusion: (Yes-No)• BPC-157 (8–6)• KPV (8–6)• TB-500 (8–6)• MOTS-c (7–5)• Epitalon (7–4)• Semax (8–5)Recommended AGAINST inclusion: (Yes-No)• DSIP (6–7) What happens […]
READ NEWS
ARTICLE
William Seeds, MD
Jul 14, 2026
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Blood Pressure Regulation
William Seeds, MD Jul 14, 2026
The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Blood Pressure Regulation
After a recent Journal Club episode in which I featured, The Renin–Angiotensin–Aldosterone System (RAAS): Beyond Cardiovascular Regulation, I wanted to return to the article and expand a bit on the significance of the Renin–Angiotensin–Aldosterone System (RAAS). As we know, the RAAS system has traditionally been viewed as the body’s primary mechanism for regulating blood pressure, […]
READ ARTICLE
World Congress World Congress
Peptide World Congress 2026
At Peptide World Congress 2026, join the fastest-growing community of evidence-based providers exploring the therapeutic power of clinical peptides. Learn why the body ages, when disease originates, and how top clinicians are changing their patients’ lives by treating the body...
22 Lessons
13 Hours 10 Minutes
View Course
ARTICLE
Scott Sherr, MD
Jul 2, 2026
Methylene Blue: From Cellular Energy to Clinical Practice
Scott Sherr, MD Jul 2, 2026
Methylene Blue: From Cellular Energy to Clinical Practice
Scott Sherr, MD | Lucía González Forte, PhD  Submitted for publication [Article] to the SSRP Institute Abstract Methylene blue (MB) is a century-old compound whose renewed relevance in clinical medicine reflects a clearer understanding of its role in mitochondrial function, redox biology, and neuroinflammatory signaling. At therapeutic oral doses, MB acts as a catalytic electron […]
READ ARTICLE